03/15/2026
Understanding mechanism matters.
OptiLIGHT IPL works by delivering controlled pulses of light that are absorbed by hemoglobin in abnormal periocular vessels. This reduces inflammatory mediators, improves meibomian gland function, and addresses ocular rosacea, a common contributor to MGD.
For practices evaluating dry eye technologies, mechanism of action should drive decision-making, not marketing language. OptiLIGHT remains the first and only FDA-approved IPL for Dry Eye Disease due to MGD.
